Tags » MDR-TB

‘India’s fight against TB lacks punch’

Published in the Hindu on December 9, 2015

“TB is the leading infectious killer, yet countries still follow old and dangerous polices,” MSF Access Campaign tweeted. 280 more words


Chennai city’s new strategy to eliminate TB

Published in The Hindu on November 23, 2015

Thanks to the Zero TB Cities project, if all goes well, Chennai may drastically reduce TB mortality, shrink the number of new cases annually and impact TB prevalence in the city in a matter of 3-5 years. 1,122 more words


MDR-TB spreads less within households

Published in the Hindu on June 24, 2015

Unlike people with drug-susceptible TB, those with multi drug-resistant TB (MDR-TB) are less likely to transmit disease to others living in the same household (also known as household contacts), a study published on June 23 in the journal PLOS Medicine found. 544 more words

World Health Organisation

TB: India study confirms Xpert diagnostic test’s superiority

Published in The Hindu on May 28, 2015

For the first time in India, the superiority of Xpert MTB/RIF over smear microscopy for bacteriological confirmation of pulmonary TB and in diagnosing MDR-TB (Multi Drug Resistant-TB) patients before initiating any treatment has been proved in a large-scale study undertaken in 2012-2013. 615 more words

World Health Organisation

TB treatment programme in India may be generating more MDR cases

Published in the Hindu on May 7, 2015

The Joint Monitoring Mission 2015 has come down heavily on the Revised National Tuberculosis Control Programme (RNTCP) and the Ministry of Health and Family Welfare for their inability to handle the MDR-TB crisis in the country. 654 more words


Working towards personalised TB treatment

Published in The Hindu on February 19, 2015

Three major global research centres in India will receive funding coming out of collaboration between the UK Medical Research Council (MRC) and the Department for Biotechnology (DBT), India. 546 more words


PaMZ drug combination: a game changer for TB and MDR-TB treatment

Published in The Hindu on April 30, 2014

A novel drug combination (PaMZ) designed to treat both drug-sensitive and MDR-TB, including those who are HIV positive, is advancing to the crucial Phase III human clinical trial. 2,269 more words